scholarly journals Outbreak of Human Parainfluenza Virus 3 Infections in a Hematopoietic Stem Cell Transplant Population

2001 ◽  
Vol 184 (9) ◽  
pp. 1093-1097 ◽  
Author(s):  
Karoll J. Cortez ◽  
Dean D. Erdman ◽  
Teresa C. T. Peret ◽  
Vee J. Gill ◽  
Richard Childs ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell ◽  
Hematopoietic Stem Cell Transplant ◽  
Stem Cell Transplant ◽  
Parainfluenza Virus ◽  
Cell Transplant ◽  
Hematopoietic Stem ◽  
Human Parainfluenza Virus

scholarly journals DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation

2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
B. Dhakal ◽  
A. D’Souza ◽  
M. Pasquini ◽  
W. Saber ◽  
T. S. Fenske ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell ◽  
Hematopoietic Stem Cell Transplant ◽  
Stem Cell Transplant ◽  
Parainfluenza Virus ◽  
Cell Transplant ◽  
Transplant Recipients ◽  
Hematopoietic Stem ◽  
Life Threatening ◽  
Type 3

Parainfluenza virus (PIV) may cause life-threatening pneumonia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Currently, there are no proven effective therapies. We report the use of inhaled DAS181, a novel sialidase fusion protein, for treatment of PIV type 3 pneumonia in two allogeneic hematopoietic SCT recipients with respiratory failure.

Sign in / Sign up

Export Citation Format

Share Document